SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ — Yuyu Pharma will attend CPHI Worldwide in Barcelona, Spain, from October 24 to 26.
Yuyu’s business development team will meet with big partners at booth No. 7G30 of the Korean Trade Association pavilion to introduce Yuyu’s export products, such as its new modified medicine Maxmarvil EC Tablet, Yuhylyx soft capsules, Yuvaro and Senuvela Tab, among others.
In particular, Yuyu will focus on promoting projects currently in development, such as a Dutasteride-Tamsulosin combination drug and a reduced size Dutasteride. These projects are being developed with the aim of entering the US and European market for benign prostatic hyperplasia.
Danny Kang, Export Director of Yuyu, stated: “As always, we look forward to active discussions with our partners at our CPHI booth. And we look forward to meeting new potential partners as well.”
About Yuyu Pharma
With over 80 years in healthcare, Yuyu Pharma (KRX: 000220) is a rapidly growing global pharmaceutical company founded in Seoul, South Korea. Yuyu is committed to the development of innovative therapies in the areas of neurology, dermatology, urology and ophthalmology. Yuyu’s mission is to improve the quality of life and well-being of all people by developing innovative healthcare products and services.
Photo – https://mma.prnewswire.com/media/2249315…
View original content: https://www.prnewswire.com/news-releases/yuyu-pharma-asistira-a-la-cphi-worldwide-2023-301961107.html
